Harrow
Richard Moriarty is an experienced professional who has held various sales and management positions in the pharmaceutical industry. With a background in Family Studies and Education, Richard has successfully managed teams and achieved sales goals in areas such as ophthalmology and pharmaceutical sales. Richard has worked with companies like Bausch + Lomb, TearLab Corporation, and Oyster Point Pharma, demonstrating a strong track record of leadership and sales success.
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.